Evidence map›Paper›PMID 22257645›Full record

Trial reportMetabolism: clinical and experimental2012

The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa.

Amy D Divasta, Henry A Feldman, Courtney Giancaterino, Clifford J Rosen, Meryl S Leboff, Catherine M Gordon

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Metabolism: clinical and experimental, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 4 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 4 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. State of the art systematic review of bone disease in anorexia nervosa.The International journal of eating disorders · 2016
    Pooled it
  5. Trial
  6. Impact of Adrenal Hormone Supplementation on Bone Geometry in Growing Teens With Anorexia Nervosa.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2019
    Trial
  7. Trial
  8. Percentage body fat by dual-energy X-ray absorptiometry is associated with menstrual recovery in adolescents with anorexia nervosa.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2014
    Trial
  9. Trial
  10. Does hormone replacement normalize bone geometry in adolescents with anorexia nervosa?Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2014
    Trial
  11. Vertebral fracture assessment in adolescents and young women with anorexia nervosa: a case series.Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry
    Trial
  12. Review
  13. Review
  14. Article
  15. Neuroendocrine adaptations to starvation.Psychoneuroendocrinology · 2023
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Low bone mineral density in anorexia nervosa: Treatments and challenges.Clinical reviews in bone and mineral metabolism · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Amy D DivastaDivision of Adolescent Medicine, Children's Hospital Boston, Boston, MA 02115, USA. amy.divasta@childrens.harvard.edu
Henry A Feldman
Courtney Giancaterino
Clifford J Rosen
Meryl S Leboff
Catherine M Gordon
Boston Children's Hospital · USBrigham and Women's Hospital · USMaine Medical Center · US

Funding

Effects of Adrenal and Gonadal HR in Young Women with ANR01HD043869 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI GORDON, CATHERINE M. · 2004 to 2010
$1.7M
Biomechanical Stimulation & Skeletal Health in Adolescents with Anorexia NervosaK23HD060066 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI DIVASTA, AMY D · 2009 to 2013
$656k
NICHD NIH HHS K23 HD060066NICHD NIH HHS R01 HD043869
6 · The paper itself

Abstract

Anorexia nervosa (AN) is characterized by subnormal estrogen and dehydroepiandrosterone (DHEA) levels. We sought to determine whether the combination of DHEA + estrogen/progestin is superior to placebo in preserving skeletal health over 18 months in AN. Females with AN, aged 13 to 27 years, were recruited for participation in this double-blind, placebo-controlled, randomized trial. Ninety-four subjects were randomized, of whom 80 completed baseline assessments and received either study drug (oral micronized DHEA 50 mg + 20 µg ethinyl estradiol/0.1 mg levonorgestrel combined oral contraceptive pill [COC] daily; n = 43) or placebo (n = 37). Serial measurements of areal bone mineral density (aBMD), bone turnover markers, and serum hormone concentrations were obtained. Sixty subjects completed the 18-month trial. Spinal and whole-body aBMD z scores were preserved in the DHEA + COC group, but decreased in the placebo group (comparing trends, P = .008 and P = .001, respectively). Bone turnover markers initially declined in subjects receiving DHEA + COC and then returned to baseline. No differences in body composition, adverse effects of therapy, or alterations in biochemical safety parameters were observed. Combined therapy with DHEA + COC appears to be safe and effective for preventing bone loss in young women with AN, whereas placebo led to decreases in aBMD. Dehydroepiandrosterone + COC may be safely used to preserve bone mass as efforts to reverse the nutritional, psychological, and other hormonal components of AN are implemented.

Indexed as

AdolescentAdultAnorexia NervosaBody CompositionBone and BonesBone DensityContraceptives, Oral, CombinedDehydroepiandrosteroneDouble-Blind MethodDrug Therapy, CombinationEstrogensEthinyl EstradiolFemaleHumansLevonorgestrelProgestinsContraceptives, Oral, CombinedDehydroepiandrosteroneEstrogensEthinyl EstradiolLevonorgestrelProgestins

Identifiers

PMID22257645
PMCPMC3465078
OpenAlexW1996219695

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.